Synthesis and anti-bacterial activity of some novel 2-(6-fluorochroman-2-yl)-1-alkyl/acyl/aroyl-1H-benzimidazoles.

doi:10.1016/J.EJMECH.2006.01.006

Paper

Synthesis and anti-bacterial activity of some novel 2-(6-fluorochroman-2-yl)-1-alkyl/acyl/aroyl-1H-benzimidazoles.

Published May 1, 2006 · B. S. Kumar, S. D. Vaidya, R. Kumar

European journal of medicinal chemistry

Q2 SJR score

91

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Highly Cited

Study Snapshot

Novel 2-(6-fluorochroman-2-yl)-1-alkyl/acyl/aroyl-1H-benzimidazoles show promising antibacterial activity against Salmonella typhimurium, but poor activity against S. aureus and disappointing anti-asthmatic and anti-d

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Synthesis and anti-bacterial activity of some novel 2-(6-fluorochroman-2-yl)-1-alkyl/acyl/aroyl-1H-benzimidazoles.

Sign up to use Study Snapshot

References

The biochemical basis of anthelmintic action and resistance.

Anthelmintic drugs target unique parasite target sites, but resistance mechanisms vary among species and isolates, posing a serious threat to effective control of helminth infections.

Synthesis and photophysical properties of fluorescent 2‐aryl‐1,3‐dialkylbenzimidazolium ions and a l‐alkyl‐2‐arylbenzimidazole with excited state intramolecular proton‐transfer

Fluorescent 2aryl-1,3dialkylbenzimidazolium ions with intramolecular proton-transfer show potential as laser dyes and scintillation fluors.

Citations

Discovery of a Novel Benzimidazole Necroptosis Inhibitor from an In-House Compound Library

Compound 1, a novel benzimidazole necroptosis inhibitor, effectively mitigates necroptosis and protects mice from TNF-induced SIRS, offering potential for developing treatments targeting diseases associated with necroptosis.

Developing Effective Antimicrobial Agents: Synthesis and Molecular Docking Study of Ciprofloxacin‐Benzimidazole Hybrids

New ciprofloxacin-benzimidazole hybrid compounds show potential antibiotic activity against various bacteria, with compounds 4 v and 4 w showing the best results.

Synthesis and Characterization of Benzimidazole Derivatives and Evaluation of Antimicrobial activity

Benzimidazole derivatives show promising antibacterial and antifungal activity, with ciprofloxacin and fluconazole as reference medications.

Synthesis, bioactivity, and molecular docking of benzimidazole-2-carbamate derivatives as potent α-glucosidase inhibitors

Benzimidazole-2-carbamate derivatives show potential as antidiabetic agents, with 7d-1 and 7f-2 showing the most effective inhibition of -glucosidase at 118 and 155 M, respectively.

Synthesis of new benzimidazole derivatives containing 1,3,4-thiadiazole: their in vitro antimicrobial, in silico molecular docking and molecular dynamic simulations studies

Compounds 4f and 4i show the best antifungal activity against Candida albicans, with promising interactions in DNA gyrase active site.

Synthesis, characterization, Hirshfeld surface analysis, and the study of antimicrobial, and acaricidal properties of copper(II) complexes with 2-(hydroxymethyl)benzimidazole ligand

Copper(II) complexes with 2-(hydroxymethyl)benzimidazole ligand show promising antimicrobial and acaricidal properties against various bacteria and yeast strains.